Induztr
Engineering Digest Document Viewer Related Models

User Guide for iCell Cardiomyocytes Assay on an xCELLigence RTCA CardioECR System

Technical Reference Summary

Covered Models & Document Scope

Optimized protocol for direct plating of one unit of iCell cardiomyocytes on an xCELLigence RTCA CardioECR system using E-Plate CardioECR 48 (Agilent p/n 300600940) and RTCA CardioECR system (Agilent p/n 380601210); covers Day 1 setup through Day 17 compound addition.

Section-by-Section Technical Breakdown

pp. 1
Reagents, Materials, and Equipment

Lists the required xCELLigence RTCA CardioECR system, CO2 incubator, laminar flow hood, multichannel pipettors, E-Plate CardioECR 48, iCell cardiomyocytes kit, fibronectin stock, and DPBS. Part numbers are given for the instrument and consumable.

  • RTCA CardioECR system: Agilent p/n 380601210
  • E-Plate CardioECR 48: Agilent p/n 300600940
  • Fibronectin stock: Sigma-Aldrich Cat. no. F1141
  • 8-channel multichannel pipettor, 20 and 200 µL
pp. 2-3
Day 1: Experiment Setup

Describes coating the E-Plate with fibronectin, measuring background, thawing/counting/seeding iCell cardiomyocytes, and replacing plating medium with maintenance medium. Includes critical cautions on room-temperature incubation, temperature equilibration, and warm medium.

  • Dilute FN stock 1:100 in DPBS to 10 µg/mL; add 50 µL per well
  • Incubate coated plate at 37 °C ≥1 h or 4 °C overnight
  • Seed 20,000 cells/well; leave 30 min at RT in laminar flow hood
  • Equilibrate 15 min in incubator before inserting into station
  • Replace Plating Medium with Maintenance Medium 48 h after seeding
  • Medium change every 48 h during culture
pp. 3
Days 2 to 14: Cell Maintenance

Covers routine maintenance medium changes every 48 hours and daily monitoring of beating activity and field potential until a synchronous beating profile is achieved. The coefficient of variation of beating period should be less than 10%.

  • Replace maintenance medium every 48 hours
  • Monitor beating activity and field potential daily
  • CV of beating period during each recording should be <10%
pp. 4
Days 14 to 16: Cell Status Quality Control (QC) before Compound Addition

Defines the QC measurement schedule and acceptance criteria for cardio mode (beating activity) and ECR mode (electrical activity). Includes recommended readings for BR, Amp, BRI, FR, and sodium spike amplitude.

  • Five sweeps of 20-second durations, one-hour interval
  • Cardio QC: BR >20 beats/min, Amp ≥0.07, BRI <0.1, CV <15%
  • ECR QC: FR >20 times/min, 90% of electrodes detect >0.3 mV sodium spike, CV <15%
  • Stable cardio signal normally achieved before stable FP signal
pp. 5-6
Day 17: Compound Addition

Details cell culture preparation, baseline measurement, compound preparation/dilution, and compound addition with short-term (<1 hour) or long-term (24 hours) monitoring schedules. Emphasizes minimizing compound addition time to 3–5 minutes.

  • Replace culture media with 90 µL fresh 37 °C media at least 4 h before compound addition
  • Baseline: seven sweeps of 60-second durations, five-minute interval
  • Prepare 1000x concentrated serial dilutions; final 10x in culture medium
  • Add 10 µL compound to E-Plate; include solvent-only negative control
  • Short-term monitoring: 13 sweeps of 60-second durations, five-minute intervals
  • Long-term monitoring: 24 sweeps of 60-second durations, one-hour intervals
  • Compound addition should not exceed 3–5 minutes

Key Integration, Operating & Safety Requirements

Specification / Condition Engineering Implication Applies To
Fibronectin coating concentration is 10 µg/mL prepared by 1:100 dilution of stock in sterile DPBS. p.2 ↗ Ensures consistent extracellular matrix coating for cardiomyocyte attachment. E-Plate CardioECR 48
Coated E-Plate can be incubated at 37 °C for at least 1 hour or at 4 °C overnight. p.2 ↗ Provides flexibility in experiment scheduling while maintaining coating integrity. E-Plate CardioECR 48
Seed 20,000 iCell cardiomyocytes per well in the E-Plate CardioECR 48. p.2 ↗ Standardized cell density for reproducible beating and field potential signals. iCell cardiomyocytes assay
After seeding, leave the plate in the laminar flow hood for 30 minutes at room temperature. p.2 ↗ Critical for even cell distribution and reliable cell performance during the assay. E-Plate CardioECR 48
Allow 15 minutes for temperature equilibration before inserting the plate into the RTCA CardioECR station. p.2 ↗ Prevents condensation on the plate bottom that would interfere with field potential signal assessment. E-Plate CardioECR 48
Impedance sampling rate is 2 or 12.8 ms; ECR sampling rate is 0.1 ms (10 kHz). p.3 ↗ Defines temporal resolution for impedance and extracellular recording measurements. RTCA CardioECR system
Replace plating medium with maintenance medium 48 hours after seeding and every 48 hours thereafter. p.3 ↗ Maintains culture health and consistent assay conditions. iCell cardiomyocytes culture
Beating signal should be detectable within 96 to 144 hours after cell seeding; beating frequency becomes more regular 10 days post-seeding. p.3 ↗ Sets expectation for when to begin monitoring and when to schedule compound testing. iCell cardiomyocytes assay
During daily monitoring, the coefficient of variation of beating period should be less than 10%. p.3 ↗ Indicates a synchronous beating profile suitable for compound testing. iCell cardiomyocytes assay
Cardio QC acceptance: BR >20 beats/min, Amp ≥0.07, BRI <0.1, CV <15% across recording time points. p.4 ↗ Defines minimum cell status quality before compound addition. iCell cardiomyocytes assay
ECR QC acceptance: FR >20 times/min, 90% of electrodes detect >0.3 mV sodium spike with consistent amplitude, CV <15%. p.4 ↗ Ensures electrical activity is sufficiently robust for field potential measurements. iCell cardiomyocytes assay
At least 4 hours before compound addition, replace culture media with 90 µL of fresh media equilibrated to 37 °C. p.5 ↗ Ensures uniform medium volumes across the E-Plate due to variable evaporation rates. E-Plate CardioECR 48
Baseline measurement uses seven sweeps of 60-second durations with five-minute intervals. p.5 ↗ Provides stable pre-treatment reference for beating and electrical activity. RTCA CardioECR system
Prepare compound stock solutions at high concentration (ideally 1000-fold of highest test concentration) and store at -20 °C if DMSO is used. p.5 ↗ Minimizes solvent toxicity and ensures accurate serial dilutions. Compound preparation
Add 10 µL of compound diluted in culture medium from a V-bottom microplate to the E-Plate CardioECR 48. p.6 ↗ Standardized compound transfer volume for reproducible dosing. E-Plate CardioECR 48
Compound addition should not exceed 3 to 5 minutes. p.6 ↗ Minimizes exposure of cells to ambient temperature and oxygen outside the incubator, preserving signal capture. Compound addition
Short-term monitoring schedule: 13 sweeps of 60-second durations with five-minute intervals; long-term: 24 sweeps of 60-second durations with one-hour intervals. p.5 ↗ Defines data acquisition cadence for acute and chronic compound effects. RTCA CardioECR system
Include wells treated with solvent only at the same final concentration as compound-treated wells for the negative control. p.6 ↗ Controls for solvent effects in the assay. Compound addition

Technical Data

Parameter Value Condition
Fibronectin coating concentration 10 µg/mL p.2 ↗ 1:100 dilution of FN stock in sterile DPBS
Fibronectin coating volume per well 50 µL p.2 ↗ E-Plate CardioECR 48
Coating incubation temperature 37 °C p.2 ↗ at least 1 hour; alternatively 4 °C overnight
Background measurement duration 1 second p.2 ↗ preset Step 1
Cell seeding density 20,000 cells/well p.2 ↗ iCell cardiomyocytes on E-Plate CardioECR 48
Room-temperature incubation after seeding 30 minutes p.2 ↗ laminar flow hood, room temperature
Temperature equilibration before station insertion 15 minutes p.2 ↗ incubator
Impedance sampling rate 2 or 12.8 ms p.3 ↗ all schedule steps
ECR sampling rate 0.1 ms (10 kHz) p.3 ↗ all schedule steps
Medium change interval 48 hours p.3 ↗ during culture
Maintenance medium volume per well 100 µL p.3 ↗ medium change
Beating signal detection window 96 to 144 hours p.3 ↗ after cell seeding
Beating period CV during monitoring <10 % p.3 ↗ each recording
Beating Rate (BR) >20 beats/min p.4 ↗ Cardio mode QC
Beating Amplitude (Amp) ≥0.07 p.4 ↗ Cardio mode QC
Beating Rhythm Irregularity (BRI) <0.1 p.4 ↗ Cardio mode QC
CV across recording time points (Cardio QC) <15 % p.4 ↗ BR and Amp
Firing Rate (FR) >20 times/min p.4 ↗ ECR mode QC
Sodium Spike Amplitude detection >0.3 mV p.4 ↗ 90% of electrodes
CV across recording time points (ECR QC) <15 % p.4 ↗ FR and sodium spike amplitude
Fresh medium volume before compound addition 90 µL p.5 ↗ at least 4 hours before compound addition, 37 °C
Compound stock storage temperature -20 °C p.5 ↗ DMSO stock, ideally 1000-fold of highest test concentration
Compound addition volume 10 µL p.6 ↗ from V-bottom microplate to E-Plate CardioECR 48
Maximum compound addition duration 3 to 5 minutes p.6 ↗ to capture electrical and beating activity changes